Alternatively, B-cell lymphoma also developed when crossing the Emu-CCND1 mouse with transgenic mice that had other genetic aberrations observed in MCL, such as BIM-deficient [37] or ATM-deficient mice [38]. This evidence concerns the gene BCL2L11 and B-cell non-Hodgkin lymphoma.